Combination of ZEN-3694 with talazoparib is a novel therapeutic approach in ER positive breast cancer resistant to CDK4/6 inhibitors, independent of BRCA status.

被引：0
|
作者：
Kharenko, Olesya A. [1 ]
Patel, Reena [1 ]
Calosing, Cyrus [1 ]
机构：
[1] Zenith Epigenet, Calgary, AB, Canada
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1129
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination of ZEN-3694 with CDK4/6 inhibitors reverses resistance in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [2] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    [J]. CANCER GENE THERAPY, 2022, 29 (06) : 859 - 869
  • [3] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Olesya A. Kharenko
    Reena G. Patel
    Cyrus Calosing
    Edward H. van der Horst
    [J]. Cancer Gene Therapy, 2022, 29 : 859 - 869
  • [4] CDK4/6 inhibitors: A potential therapeutic approach for triple negative breast cancer
    Saleh, Lubaid
    Wilson, Caroline
    Holen, Ingunn
    [J]. MEDCOMM, 2021, 2 (04): : 514 - 530
  • [5] Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer
    Eskiler, G. Guney
    Ozman, Z.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 697 - 698
  • [6] Therapeutic targeting of CDK4/6 inhibitor resistant breast cancer
    Lim, Elgene
    Portman, Neil
    Alexandrou, Sarah
    Haupt, Susan
    Haupt, Ygal
    Caldon, Elizabeth
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [7] Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
    Wu, Yanmei
    Zhang, Yu
    Pi, Hao
    Sheng, Yuan
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3477 - 3487
  • [8] Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer
    Kase, Adam M.
    Copland, John A., III
    Tan, Winston
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 10499 - 10513
  • [9] CDK4/6 inhibitors in HER2-positive breast cancer
    Corona, Silvia Paola
    Ravelli, Andrea
    Cretella, Daniele
    Cappelletti, Maria Rosa
    Zanotti, Laura
    Dester, Martina
    Gobbi, Angela
    Petronini, Pier Giorgio
    Generali, Daniele
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 112 : 208 - 214
  • [10] DNA replication licensing is associated with resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Nanda, Sarmistha
    Shea, Martin J.
    Schiff, Rachel
    Osborne, C. Kent
    Rimawi, Mothaffar
    Fu, Xiaoyong
    [J]. CANCER RESEARCH, 2023, 83 (05)
12345